[Form 4] ESAB Corporation Insider Trading Activity
Rhonda L. Jordan, a director of ESAB Corporation, reported transactions dated 08/13/2025. The filing shows an option exercise/acquisition of 4,067 shares at a $33.02 exercise price and contemporaneous sales of 4,067 shares at a weighted-average price of $113.047, leaving zero shares held directly after the transactions. The exercised options were originally exercisable beginning 04/05/2022 and expire 05/13/2026. The report also discloses indirect holdings: 6,003 shares held by a family trust, 292 shares held by a trust for the reporting person’s spouse, and 2,037 shares held by the spouse. A footnote states the sale prices ranged from $113.000 to $113.340 and that the reporting person disclaims beneficial ownership of the indirect holdings except for pecuniary interest.
- None.
- Insider sold 4,067 shares (weighted-average price $113.047) on 08/13/2025, leaving zero direct holdings after the transactions
- Direct ownership reduced to zero despite remaining indirect holdings, which may limit the director's immediate direct stake
Insights
TL;DR: Director exercised options and sold the resulting shares the same day, leaving no direct holdings.
The Form 4 documents a routine exercise of stock options (4,067 shares at a $33.02 exercise price) followed by sales of the same 4,067 shares at a weighted-average price of $113.047 on 08/13/2025. The timing and matching quantities suggest the transactions were linked (exercise then sale). While the director no longer holds these shares directly, material indirect positions remain via family and spouse trusts totaling 8,332 shares. For investors, this is a disclosure of insider liquidity activity rather than an operational development; it does not provide information about company performance or guidance.
TL;DR: Insider complied with Section 16 reporting; transactions are fully disclosed with explanatory footnotes.
The filing includes standard explanatory language: a weighted-average sale price range for the disposed shares and a disclaimer regarding indirect beneficial ownership. The option grant/exercise dates and expiration (exercisable 04/05/2022, expiring 05/13/2026) are specified, which supports transparency. No amendment flag is indicated and the form is signed by an attorney-in-fact, consistent with typical insider reporting practice.